Log in
The Integrated E-Z Split Key Cup simplifies urine drug screening by combining specimen collection and testing into one secure device. Since the urine remains inside the sealed collection cup throughout the testing process, exposure to the specimen is minimized while helping reduce handling errors and opportunities for tampering.
Its integrated design improves workflow efficiency and provides a convenient solution for organizations that require rapid, reliable drug screening with minimal training
Using the Integrated 12 Panel E-Z Split Key Cup is quick and straightforward:
Collect a fresh urine specimen directly into the collection cup.
Secure the leak-proof lid immediately after collection.
Activate the test using the built-in test initiation mechanism according to the product instructions.
Place the cup on a flat surface while the test develops.
Read the results within the recommended reading time (approximately 5 minutes).
If required, retain the sealed specimen for laboratory confirmation testing
50 ng/mL (Urine)
Marijuana contains Delta-9-tetrahydrocannabinol (THC), the primary psychoactive compound responsible for cannabis intoxication. It affects memory, concentration, coordination, and judgment. Although marijuana is used medically in some regions, recreational use remains one of the most commonly detected substances in workplace drug testing.
Relaxation
Euphoria
Increased appetite
Altered perception
Reduced concentration
Slower reaction time
Poor coordination
Anxiety
Weed, Pot, Ganja, Grass, Mary Jane, Herb, Bud.
Typically detectable in urine for 3–30 days, depending on frequency of use
150 ng/mL (Urine)
Cocaine is a powerful stimulant derived from coca leaves that rapidly increases dopamine levels in the brain. It produces short-term euphoria but has a high potential for abuse and addiction.
Increased energy
Alertness
Euphoria
Rapid heartbeat
Elevated blood pressure
Anxiety
Restlessness
Loss of appetite
Coke, Blow, Snow, Flake, Crack, Rock, Yayo, Nose Candy.
Generally detectable in urine for 2–4 days
1000 ng/mL (Urine)
Amphetamines are prescription stimulants commonly used to treat ADHD and narcolepsy. Misuse can result in dependence and serious cardiovascular and neurological complications.
Increased energy
Alertness
Reduced fatigue
Loss of appetite
Rapid heartbeat
Elevated blood pressure
Insomnia
Anxiety
Speed, Uppers, Bennies, Dexies, Addys.
Generally detectable in urine for 2–4 days
1000 ng/mL (Urine)
Methamphetamine is a highly addictive stimulant that strongly affects the central nervous system. Long-term use can lead to severe physical and psychological dependence.
Increased energy
Euphoria
Rapid heartbeat
Restlessness
Insomnia
Anxiety
Aggressive behavior
Reduced appetite
Meth, Crystal Meth, Ice, Glass, Tina, Crank.
Generally detectable in urine for 2–5 days
500 ng/mL (Urine)
MDMA, commonly known as Ecstasy or Molly, is a synthetic stimulant with mild hallucinogenic properties that alters mood and sensory perception.
Euphoria
Emotional warmth
Increased energy
Enhanced sensory perception
Jaw clenching
Sweating
Increased body temperature
Anxiety
Ecstasy, Molly, XTC, E, Rolls.
Generally detectable in urine for 2–4 days.
300 ng/mL (Urine)
Barbiturates are sedative-hypnotic medications used to treat seizures, anxiety, and insomnia. They have a significant potential for misuse and dependence.
Drowsiness
Relaxation
Slurred speech
Poor coordination
Fatigue
Confusion
Reduced judgment
Slowed breathing
Barbs, Downers, Reds, Yellow Jackets.
Typically detectable in urine for 2–15 days
300 ng/mL (Urine)
Benzodiazepines are prescription medications used to treat anxiety, insomnia, and seizure disorders. Misuse may result in physical dependence and withdrawal symptoms.
Relaxation
Drowsiness
Muscle relaxation
Poor coordination
Memory impairment
Reduced concentration
Slowed reaction time
Confusion
Benzos, Xanax, Bars, Valium, Ativan.
Generally detectable in urine for 3–30 days
100 ng/mL (Urine)
Oxycodone is a prescription opioid used for moderate to severe pain management. Due to its euphoric effects, it has a high potential for misuse.
Pain relief
Relaxation
Drowsiness
Euphoria
Slowed breathing
Nausea
Dizziness
Constricted pupils
Oxy, Roxies, Blues, Percs.
Generally detectable in urine for 2–4 days
10 ng/mL (Urine)
Buprenorphine is a partial opioid agonist used in opioid dependence treatment and chronic pain management.
Pain relief
Relaxation
Drowsiness
Dizziness
Nausea
Reduced cravings
Slowed breathing
Constricted pupils
Suboxone, Subutex, Bupe, Subs.
Generally detectable in urine for 3–7 days
300 ng/mL (Urine)
Methadone is a long-acting synthetic opioid commonly prescribed for opioid dependence treatment and chronic pain.
Pain relief
Drowsiness
Relaxation
Slowed breathing
Dizziness
Nausea
Fatigue
Constricted pupils
Methadose, Done, Juice.
Generally detectable in urine for 3–7 days
300 ng/mL (Urine)
Propoxyphene is a synthetic opioid analgesic that was formerly prescribed for the treatment of mild to moderate pain. Although it has been withdrawn from the market in many countries due to safety concerns, it may still be included in multi-panel drug tests to identify previous exposure or misuse.
Pain relief
Drowsiness
Dizziness
Relaxation
Nausea
Slowed breathing
Reduced alertness
Poor coordination
Long-term misuse may lead to opioid dependence, respiratory depression, cardiac complications, and overdose.
Darvon, Darvocet, PPX.
Generally detectable in urine for 1–3 days
300 ng/mL (Urine)
Morphine is a prescription opioid used to treat moderate to severe pain. It is also one of the primary metabolites of heroin and codeine, making it an important marker in urine drug testing.
Pain relief
Relaxation
Drowsiness
Slowed breathing
Constricted pupils
Dizziness
Nausea
Reduced reaction time
M, Miss Emma, Dreamer, Morph.
Generally detectable in urine for 2–3 days
The Integrated 12 Panel E-Z Split Key Cup provides a convenient and reliable solution for rapid urine drug screening by combining specimen collection and testing in a single integrated device. Its secure, leak-resistant design minimizes specimen handling while delivering preliminary results for 12 commonly abused drugs in approximately 5 minutes. Suitable for workplace, clinical, rehabilitation, and forensic settings, this test offers an efficient screening solution, with any preliminary positive result requiring confirmation by an approved laboratory method such as GC-MS or LC-MS/MS.
The Integrated 12 Panel E-Z Split Key Cup is a rapid, all-in-one urine drug screening device designed to simultaneously detect 12 commonly abused drugs and their metabolites in a single urine specimen. Its fully integrated design combines specimen collection and drug testing into one secure cup, eliminating the need for urine handling and reducing the risk of contamination or donor tampering.
The E-Z Split Key Cup delivers fast, easy-to-read preliminary results in approximately 5 minutes, making it an excellent choice for point-of-care testing in workplace, clinical, rehabilitation, and forensic settings. The integrated test system helps streamline the testing process while maintaining accuracy and convenience.
This 12-panel configuration screens for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), MDMA (Ecstasy), Barbiturates (BAR), Benzodiazepines (BZO), Oxycodone (OXY), Buprenorphine (BUP), Methadone (MTD), Propoxyphene (PPX), and Morphine (MOP).
As with all rapid urine drug screens, the test provides preliminary qualitative results only. Any preliminary positive result should be confirmed using a certified laboratory method such as Gas Chromatography-Mass Spectrometry (GC-MS) or Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Urine drug testing remains one of the most widely accepted methods for detecting recent drug use because many drugs and their metabolites are naturally eliminated through urine. Rapid urine screening offers a non-invasive, cost-effective solution for workplace, clinical, and forensic testing programs.
The Integrated 12 Panel E-Z Split Key Cup provides simultaneous screening for twelve commonly abused substances while minimizing specimen handling. The integrated collection cup helps improve safety, simplify testing procedures, and reduce the likelihood of specimen contamination.
This test provides preliminary qualitative screening results only. Any non-negative (preliminary positive) result should be confirmed using an approved laboratory confirmation method such as GC-MS or LC-MS/MS
This Integrated 12 Panel Drug Test Cup screens for:
Drug
Typical Detection Time
Marijuana (THC)
3–30 Days
Cocaine (COC)
2–4 Days
Amphetamine (AMP)
2–4 Days
Methamphetamine (mAMP)
2–5 Days
MDMA
2–4 Days
Barbiturates (BAR)
2–15 Days
Benzodiazepines (BZO)
3–30 Days
Oxycodone (OXY)
2–4 Days
Buprenorphine (BUP)
3–7 Days
Methadone (MTD)
3–7 Days
Propoxyphene (PPX)
1–3 Days
Morphine (MOP)
2–3 Days
Drug
Screening Cutoff
Marijuana (THC)
50 ng/mL
Cocaine (COC)
150 ng/mL
Amphetamine (AMP)
1000 ng/mL
Methamphetamine (mAMP)
1000 ng/mL
MDMA
500 ng/mL
Barbiturates (BAR)
300 ng/mL
Benzodiazepines (BZO)
300 ng/mL
Oxycodone (OXY)
100 ng/mL
Buprenorphine (BUP)
10 ng/mL
Methadone (MTD)
300 ng/mL
Propoxyphene (PPX)
300 ng/mL
Morphine (MOP)
300 ng/mL
EZII 12 Panel Cup Drug Test 12 Panel Drug Test Cup for mAMP/MDMA/THC/BZO/MTD/BAR/AMP/MOPI/OXY/PPX/COC/BUP | Abbott DOA-1127-041-19 25/Box
Sign up for updates from leading retailers
